Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety

Sponsor: Salutare Group Ltd.

NCT ID: NCT07104955

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
MDT referral and review software (other)
How long the study runs
Study runs about 12 months (dates as stated)
About the drug or intervention
MDT referral and review software — other: Use of the multi-disciplinary team (MDT) meeting software to submit, review and discuss referrals
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
Not specified
Who
All
Number of participants
40
Started
2025-07-31
Last checked
2025-08

Plain English Summary

What is this study?

  • • Testing a new treatment for cancer (solid tumors)
  • • NA - 40 participants
  • • Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information

Who can take part?

  • • Adults
  • • Diagnosed with cancer (solid tumors)

Where?

  • • London - Royal National Orthopaedic Hospital

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information. This can lead to delays in treatment decisions, potentially incomplete care plans, or the need to repeatedly discuss the same patient cases. This study aims to test a new software called Salutare One Referral. One Referral is designed to make these meetings more efficient and effective. We want to see if this software can help healthcare staff prepare MDT referral information more easily and facilitate a more informed MDT discussion, which could lead to better patient care. If successful, this could help improve how MDTs operate across the NHS.

More detail

This study aims to evaluate the safety, implementation effectiveness and feasibility of the Salutare One Referral software, a new tool designed to enhance Multi-Disciplinary Team (MDT) meetings. MDT meetings are recognized as the preferred means of delivering complex care for both chronic and acute diseases. However, there remains significant diversity in the purpose, structure, processes, and content of MDT meetings, as well as in how effectively they have been integrated into clinical practice. Common issues observed in MDTs include: * Deferring discussions due to incomplete medical history * Re-discussing the same cases due to inadequate recording of previous discussions * Failure to systematically manage cases to meet local and national targets The Salutare One Referral software is designed to address these challenges by streamlining the referral process, improving information sharing, and enhancing decision-making processes in MDT meetings. By potentially enhancing MDT efficiency, this study could lead to faster and better-coordinated patient care, reducing delays in treatment planning and implementation. Study Design: This is a "before and after" study, observing MDT operations without the software, then with the software, followed by another period without it. MDT members will use the Salutare One Referral software during their regular meetings and complete questionnaires about their experience. The study will also analyse pseudonymized patient data to assess any changes in MDT review effectiveness. If successful, this study could lead to more efficient and effective MDT meetings, potentially resulting in improved patient care coordination across the NHS.

Cancer (Solid Tumors)Sarcoma

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: Not specified
  • Who can join: All genders

What the study is looking for

  • ✓MDT meeting Panel Members, Coordinators and staff submitting MDT referrals will take part in this study.

Who cannot take part

  • ✗MDT meeting Panel Members, Coordinators and staff submitting MDT referrals who are unwilling or unable to take part...
See the full criteria
Inclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals will take part in this study. Exclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals who are unwilling or unable to take part in the study.

Where Is This Study? (1 UK site)

Royal National Orthopaedic Hospital

London HA7 4LP, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Liba Stones, MA, MBA

Sponsor contact

CONTACT

+447443940319 liba@dicro.co.uk

Chris Dial

Sponsor contact

CONTACT

+447759521985 chris@salutare.co.uk
Data sourced from ClinicalTrials.gov · Last verified: 2025-08